About Hexima Limited (ASX:HXL)

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
Melbourne,Victoria,AU
Description
Information
Hexima is a clinical stage, anti-infectives focused biotechnology company engaged in the research and development of plant defensin peptides for applications as human therapeutics. Our lead product candidate, pezadeftide (formally HXP124) applied in a topical formulation, is a potential new prescription treatment for toenail fungal infections (or onychomycosis). Hexima is currently conducting an Australian phase IIb clinical trial testing pezadeftide for the treatment of onychomycosis. Hexima holds granted, long-life patents protecting pezadeftide in major markets globally.

Hexima Limited (ASX:HXL) Alternatives

Industry
biotechnology
Industry
Biotechnology
Industry
biotechnology

Frequently Asked Questions about Hexima Limited (ASX:HXL)

What is Hexima Limited (ASX:HXL) email format?

The widely used Hexima Limited (ASX:HXL) email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.


What is Hexima Limited (ASX:HXL) customer service number?

To contact Hexima Limited (ASX:HXL) customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more